SOPHiA GENETICS

Boston,  MA 
United States
http://www.sophiagenetics.com
  • Booth: 18049a

SOPHiA GENETICS is a health tech company democratizing data-driven medicine to improve health outcomes and economics worldwide. By unlocking the power of Data-Driven Medicine, the universal SOPHiA DDM Platform allows clinical researchers to act with precision and confidence. The company’s innovative approach enables an ever-expanding community of over 1’000 institutions to benefit from knowledge sharing, fostering a new era in healthcare.

Brands: https://events.jspargo.com/ASCO21/CUSTOM/sophiabanner.png


 Show Specials

  • <iframe width="560" height="315" src="https://www.youtube.com/embed/5rNln_U3XqA" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>

 Press Releases


 Products

  • SOPHiA DDM™ for Oncology
    Using data-driven medicine, clinical researchers supplement their own experience and intuition with data insights and shared knowledge from their peers to inform their decisions. From targeted to comprehensive profiling, SOPHiA GENETICS supports clinical researchers in their journey to analyze solid tumors and hematological malignancies. The universal SOPHiA DDM™ platform is used to compute different digital health data modalities separately or together and to combine genomic and phenotypic data to deliver insightful information to further advance our global understanding of cancer....

  • SOPHiA DDM™ for BioPharma
    SOPHiA GENETICS is a health tech data and analytics company revolutionizing data-driven medicine. Biopharma clients leverage our decentralized digital health analytics platform powered by artificial intelligence (AI) algorithms to solve bottlenecks throughout the drug development process, especially in translational research. By breaking down data silos, we are able to accurately interrogate molecular and imaging data sets and correlate multi-modal features with clinical data to extract subtle biomarker signatures. Our AI-based algorithms support informed decision-making for research purposes by enabling fast discovery of novel and clinically relevant biomarkers. Our recognized leadership in the analyses of complex NGS and medical imaging data is evident in the global adoption of SOPHiA GENETICS’ cloud-based AI platform. The SOPHiA DDMTM platform has been adopted by >1000 customers and top biopharma companies across 85 countries. Together, these institutions contribute to create one of the broadest clinical genomics database worldwide, which includes >700’000 genomic profiles in oncology, rare disorders and infectious disease (COVID-19) and is growing at an unprecedented rate....